Skip to content

Cytokeratin 7 (CK7) and Thyroid Transcription Factor-1 (TTF-1) Antigens, Tissue — Immunohistochemistry

Published: August 9, 2026Updated: August 17, 2026

A tissue pathology test that detects CK7 and TTF-1 proteins to help identify the likely origin of certain cancers.

Quick summary

["This test helps a pathologist classify certain cancers by showing whether tumor cells contain CK7 and TTF-1 proteins."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
74491-2
Short code
CK7+TTF-1 Ag Tiss ImStn
Synonyms
CK7+TTF-1 Ag Tiss ImStn
Category
thyroid
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
22
Ref high
198
Critical range
— – 10000 N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
immune-stain
CPT
82553
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What is this test?

This is an immunohistochemical test performed on a tissue sample, usually a biopsy or surgical specimen. It uses antibodies to detect two proteins: cytokeratin 7 (CK7) and thyroid transcription factor-1 (TTF-1).

Why might I need this test?

Pathologists may use these stains when the tissue origin of a tumor is unclear. The pattern of staining can help narrow the possibilities, such as distinguishing among tumors that can resemble one another under the microscope.

How is the test performed?

A laboratory applies special antibodies to a prepared tissue slide and examines whether the tumor cells show staining. A pathologist interprets the results together with the tissue appearance, other laboratory tests, and your medical history.

How do I prepare for the test?

No special preparation is needed if tissue has already been collected. If a biopsy or surgery is required, follow the instructions provided by your healthcare team, including any medication or fasting directions.

Reference range

Adult males: 22-198 U/L; Females: 22-198 U/LN/A

Specimen: serum

No special preparation required. Inform provider of any chest pain or symptoms.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

CK7 and TTF-1 staining patterns can support or narrow a diagnosis of cancer, particularly when evaluating tumors that may arise from the lung, thyroid, breast, or another site. Neither stain is completely specific, so results should not be interpreted in isolation. Your doctor will explain how the findings fit with your pathology report and overall clinical picture.

Short name

CK7 and TTF-1 immunostains

Frequently asked questions

Does a positive CK7 or TTF-1 result mean I have cancer?
No. These proteins may be detected in normal cells as well as in some cancers, and positive staining must be interpreted with the tissue findings and other test results.
Is this test the same as a blood test?
No. It is performed on tissue obtained through a biopsy or surgery rather than from a blood sample.
How long does it take to get the results?
Timing varies with the laboratory and the need for additional stains. Your healthcare team can provide an estimated result time and explain when the final pathology report will be available.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy